This presentation took place at The 2022 OPEN MINDS Performance Management Institute and examined the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and strategies for effective management of depression in CKD. Featured speakers:

• Aaron Emmel, PharmD, MHA, BCPS, Nephrology Senior Clinical & Scientific Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
• Aneta Fornal, PharmD, Clinical & Scientific Director, Otsuka Pharmaceutical Development & Commercialization, Inc.